Lombard Odier & Cie (Canada)’s Teva Pharmaceuticals TEVA Stock Holding History

Lombard Odier & Cie (Canada)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,500	Closed	-$81K	–	149
2014 Q3	$81K	Hold	1,500	–	–	0.05%	114
2014 Q2	$79K	Hold	1,500	–	–	0.05%	119
2014 Q1	$79K	Hold	1,500	–	–	0.06%	105
2013 Q4	$60K	Buy	+1,500	New	+$59.1K	0.06%	95

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Lombard Odier & Cie (Canada)'s TEVA Position: Q4 2014 in Review

Lombard Odier & Cie (Canada) sold out of Teva Pharmaceuticals (TEVA) in Q4 2014, closing a stake of 1,500 shares — an estimated $81K sold.

Lombard Odier & Cie (Canada) first reported a position in TEVA in Q4 2013 and held it in 4 quarters. The position peaked at $81K in Q3 2014. 821 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

Lombard Odier & Cie (Canada) reported no remaining Teva Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Lombard Odier & Cie (Canada) sold 1,500 Teva Pharmaceuticals shares in Q4 2014, an estimated $81K.
Lombard Odier & Cie (Canada) first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 4 quarters.
Lombard Odier & Cie (Canada)'s Teva Pharmaceuticals position peaked at $81K in Q3 2014.
821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Lombard Odier & Cie (Canada)'s 13F filing for Q4 2014, filed 13 Feb 2015.